Table 7 Mortality-related outcome data from studies of cancer patients treated with irinotecan, stratified by UGT1A1 genotype

From: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review